Longeveron Inc. (LGVN) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-17 19:22:21 ET
Longeveron Inc. (LGVN) Q4 2025 Earnings Call March 17, 2026 4:30 PM EDT
Company Participants
Stephen Willard - Chief Executive Officer
Nataliya Agafonova - Chief Medical Officer
Lisa Locklear - CFO, Executive VP & Treasurer
Joshua Hare - Co-Founder, Chief Science Officer & Executive Chairman
...
Read the full article on Seeking Alpha
For further details see:
Longeveron Inc. (LGVN) Q4 2025 Earnings Call Transcript
Longeveron Inc.
NASDAQ: LGVN
LGVN Trading
-3.35% G/L:
$0.9061 Last:
540,120 Volume:
$0.945 Open:
LGVN Latest News
March 18, 2026 11:30:00 am
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven't Noticed
March 18, 2026 10:00:00 am
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
March 17, 2026 04:05:00 pm
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
LGVN Stock Data
$11,788,550
19,476,920
5.23%
12
N/A
Biotechnology & Life Sciences
Healthcare
US
Miami
